Overview

Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to assess the pharmacokinetic profile in patients with active ulcerative colitis and compare it to the experience in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Lycera Corp.